Haloperidol Oral Solution

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition

Issued and maintained by the United States Pharmacopeial Convention (USP)

DOWNLOAD PDF HERE

1 DEFINITION

Haloperidol Oral Solution is a solution of Haloperidol in Water, prepared with the aid of Lactic Acid. It contains NLT 90.0% and NMT 110.0% of the labeled amount of haloperidol (C₂₁H₂₃CIFNO₂).

2 IDENTIFICATION

A. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.

3 ASSAY

3.1 PROCEDURE

Buffer solution: 6.8 g/L of monobasic potassium phosphate in water. Adjust with phosphoric acid to a pH of 4.0.

Mobile phase: Methanol and Buffer solution (55:45)

Standard stock solution: 1 mg/mL of USP Haloperidol RS in methanol. Sonicate to aid in dissolution.

Standard solution: 0.2 mg/mL of USP Haloperidol RS in Mobile phase from the Standard stock solution

Sample solution: Nominally, 0.2 mg/mL of haloperidol in Mobile phase from a volume of Haloperidol Oral Solution. Filter a portion to use in the analysis.

3.2 Chromatographic system

(See Chromatography (621), System Suitability.)

Mode: LC

Detector: UV 247 nm

Column: 4.6-mm × 15-cm; 5-µm packing L1

Flow rate: 0.8 mL/min

Injection size: 10 µL

Run time: 2.5 times the retention time of haloperidol

3.3 System suitability

Sample: Standard solution

Suitability requirements

Tailing factor: NMT 2.0

Relative standard deviation: NMT 2.0%

3.4 Analysis

Samples: Standard solution and Sample solution

Calculate the percentage of the labeled amount of haloperidol (C₂₁H₂₃CIFNO₂) in the portion of Oral Solution taken:

Result = (r_U/r_S) x (C_S/C_U) x 100

r_U = peak response from the Sample solution

r_S = peak response from the Standard solution

C_S = concentration of USP Haloperidol RS in the Standard solution (mg/mL)

C_U = nominal concentration of haloperidol in the Sample solution (mg/mL)

Acceptance criteria: 90.0%-110.0%

4 PERFORMANCE TESTS

4.1 DELIVERABLE VOLUME (698)

Meets the requirements for oral solution packaged in multiple-unit containers

4.2 UNIFORMITY OF DOSAGE UNITS (905)

Meets the requirements for oral solution packaged in single-unit containers

5 SPECIFIC TESTS

PH (791): 2.75-3.75

6 ADDITIONAL REQUIREMENTS

6.1 PACKAGING AND STORAGE

Preserve in tight, light-resistant containers. Store at controlled room temperature.

6.2 USP REFERENCE STANDARDS (11)

USP Haloperidol RS